Link's Take On The ...
Health Care: Drugs
NovaBay Pharmaceuticals Inc. (NBY: AMEX)
$1.32 -0.02 | -1.49%
06/19/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -7.03M | -5.08M | -4.31M | 2.70M |
| Operating Gains/Losses | -1.17M | 37.00K | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -940.00K | 497.00K | 3.25M | -3.80M |
| (Increase) Decrease in Inventories | -23.00K | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 665.00K | 345.00K | -319.00K | -70.00K |
| (Decrease) Increase In Other Current Liabilities | -8.00K | -1.44M | 1.52M | -2.00M |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | -3.25M | 34.00K |
| Other Non-Cash Items | 1.58M | 1.95M | 4.66M | 1.32M |
| Net Cash From Continuing Operations | -6.53M | -3.14M | 2.03M | -1.65M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -6.53M | -3.14M | 2.03M | -1.65M |
| Sale of Property, Plant & Equipment | 6.00K | 0.00 | 0.00 | 2.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 6.38M | 3.04M | 1.46M | 3.64M |
| Purchases of Property, Plant & Equipment | -148.00K | -119.00K | -203.00K | -731.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -4.87M | -7.58M | -2.45M | -3.98M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 1.36M | -4.66M | -1.19M | -1.07M |
| Issuance of Debt | 0.00 | 88.00K | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 2.89M | 103.00K | 79.00K | 2.02M |
| Repayment of Long-Term Debt | -71.00K | -123.00K | -371.00K | -408.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 6.66M | 4.63M | 0.00 | 0.00 |
| Net Cash From Financing Activities | 9.47M | 4.70M | -292.00K | 1.61M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 4.31M | -3.11M | 542.00K | -1.11M |
Portfolios with NBY
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- Contributor10 Biotech Stocks Expected ...
- UserRAPTOR SPRTD-0705091614
- Usermartynorm Portfolio 1
Latest NBY Headlines from TheStreet
- NovaBay Supports Legislation To Attack Antibiotic Resistance 06.17.13 | 08:06 am
- NovaBay Pharmaceuticals Mid-Year Clinical Update 06.11.13 | 08:06 am
- NovaBay Pharmaceuticals And Virbac Enter Into A Collaboration And License Agreement For Animal Health 05.28.13 | 03:05 am
- NovaBay Pharmaceuticals Reports First Quarter Financial Results And Clinical And Business Update 05.02.13 | 08:05 am
- NovaBay Global Ophthalmology Study Enrolls First Patients In Brazil 04.08.13 | 07:04 am
- NovaBay CEO Interviewed On RedChip Money Report On Fox Business News 03.18.13 | 06:03 am
- NovaBay Pharmaceuticals Reports Fourth Quarter Financial Results And 2013 Clinical And Business Update 03.14.13 | 06:03 am
- NovaBay Pharmaceuticals To Present At The 25th Annual ROTH Conference 03.12.13 | 07:03 am
- NovaBay Names Keith Bley As Senior Vice President Of Product Development 03.11.13 | 07:03 am
- NovaBay Receives Unique Globally Recognized International Nonproprietary Name Auriclosene For NVC-422 02.20.13 | 07:02 am
Press Releases for NBY
Partner Headlines for NBY
- NovaBay: Working On An Effective Treatment For Viral Conjunctivitis - Seeking Alpha 04.13.13 | 08:04 am
- For NovaBay, Simplicity Is The Father Of Invention - Seeking Alpha 11.12.12 | 09:11 am
- Who Is Paying Attention To MRSA? - Seeking Alpha 10.23.12 | 09:10 am
- The Company You Keep Speaks Volumes: Novabay And Trius - Seeking Alpha 10.09.12 | 09:10 am
- Diverse Pipeline And Multiple Catalysts Point To Buying Opportunity In NovaBay Pharmaceuticals - Seeking Alpha 09.06.12 | 09:09 am
- 5 BioPharmas To Watch For Wednesday, September 5 - Seeking Alpha 09.05.12 | 09:09 am
- Novabay Announces Neutrophase Available in Spray Pump - Benzinga 08.27.12 | 09:08 am
- NovaBay Pharmaceuticals: A Potential Bargain With Catalysts Pending - Seeking Alpha 06.13.12 | 09:06 am
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
- NovaBay Pharmaceuticals: Key Deal Marks A Year Of Swift Progression - Seeking Alpha 01.10.12 | 08:01 am
